Monterey Bio Acquisition Corporation

Share · US61240F1084 · MTRY (XNAS)

Overview

No Price

n/a

Share Float & Liquidity

Free Float 25,28 %

Shares Float 1,1 M

Shares Outstanding 4,34 M

Company Profile for Monterey Bio Acquisition Corporation Share

Monterey Bio Acquisition Corporation does not have significant operations. It focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or related business combination with one or more businesses in the biotech industry. The company was formerly known as Chardan FinTech Acquisition Corp. and changed its name to Monterey Bio Acquisition Corporation in April 2021. Monterey Bio Acquisition Corporation was incorporated in 2020 and is based in New York, New York.

Get up to date insights from finAgent about Monterey Bio Acquisition Corporation

Company Data

Name Monterey Bio Acquisition Corporation

Company Monterey Bio Acquisition Corporation

Symbol MTRY

Website https://www.montereybio.com

Primary Exchange

NASDAQ

ISIN US61240F1084

Asset Class Share

Sector Financial Services

Industry Shell Companies

CEO Murat Omur

Market Capitalization 48 Mio

Country United States of America

Currency USD

Employees -

Address 17 State Street, 10004 New York City

IPO Date 2021-11-22

Ticker Symbols

Name	Symbol
NASDAQ	MTRY

More Shares

Investors who hold Monterey Bio Acquisition Corporation also have the following shares in their portfolio:

AFLAC 16/26 Bond

PERUSA.LISTR 17/27 REGS Bond

The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.

Imprint Data Protection Blog Community Feedback Changelog